NCT00667121 2025-02-14
Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
Mayo Clinic
Completed
Clinical Trials
9 trialsNCT00569543 2023-09-01
Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer
University of Nebraska
Completed
NCT00959244 2023-09-01
Study of Urine Samples From Women With Newly Diagnosed Breast Cancer Enrolled on Clinical Trial UNMC-08105
University of Nebraska
Completed
NCT00900055 2022-07-05
Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma
OHSU Knight Cancer Institute
Completed
NCT00897208 2018-10-05
Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer
Mayo Clinic
Completed
NCT00516698 2016-07-13
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Alliance for Clinical Trials in Oncology
Completed
NCT00984919 2016-02-15
Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers
Barbara Ann Karmanos Cancer Institute
Completed
NCT00346008 2013-05-30
Studying Genes to Identify Melanoma in Patients in Iceland and Their Family Members
National Cancer Institute (NCI)
Completed
NCT00283608 2011-05-16
Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast Cancer
Mayo Clinic
Completed